Bangladesh inked a Memorandum of Understanding (MoU) with China on Monday to produce COVID-19 vaccine developed by China National Pharmaceutical Group (Sinopharm).
According to the MoU, Bangladesh pharmaceutical company Incepta will be able to produce at least 5 million doses of COVID-19 vaccines monthly to fight against the epidemic worsened by the spread of Delta variant.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3